| 000 | 01897 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515003336.0 | ||
| 264 | 0 | _c20060209 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2005.02652.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aErichsen, K | |
| 245 | 0 | 0 |
_aEffects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cNov 2005 |
||
| 300 |
_a831-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntioxidants _xanalysis |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aDinoprost _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFerric Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aFerrous Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aHematinics _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 | _aIron Deficiencies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xphysiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xadministration & dosage |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xurine |
| 700 | 1 | _aUlvik, R J | |
| 700 | 1 | _aGrimstad, T | |
| 700 | 1 | _aBerstad, A | |
| 700 | 1 | _aBerge, R K | |
| 700 | 1 | _aHausken, T | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 22 _gno. 9 _gp. 831-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2005.02652.x _zAvailable from publisher's website |
| 999 |
_c15853906 _d15853906 |
||